ARCHIVES

Two-Month Survival Benefit For Some NSCLC Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

Obey Aide Objects To Criticism Over Earmarking New NCI Positions

August 13, 1976

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011